Cramer: Intuitive Surgical too expensive with J&J as competitor
FROM THE WIRE · FINANCE.YAHOO.COM
During the October 5 episode of Mad Money, a caller asked whether Intuitive Surgical, Inc. (NASDAQ:ISRG) was a broken stock and whether they should consider buying it. Jim Cramer replied: I don't like that particular business anymore because there's too many companies that want…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bearishInfluential analyst warns against ISRG at 37x earnings due to J&J competition with AAA balance sheet.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Cramer deems Intuitive Surgical overvalued despite solid fundamentals.
- 02J&J enters robotic surgery market with significant financial advantages.
- 03ISRG posted 19% revenue growth in Q2 to $2.89 billion.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Intuitive Surgical, Inc.414.52 USDMarket closedtoday +2.41%Negative Johnson & Johnson258.45 USDMarket closedtoday +1.44%Positive
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets